Alexandria Real Estate Equities stock (US0152711022): Earnings outlook and life science demand in fo
Alexandria Real Estate Equities specializes in owning and developing life science and technology campuses, focusing on critical US innovation clusters. The company's latest quarterly results highlight strong leasing activity despite macroeconomic and interest-rate challenges. The article discusses Alexandria Real Estate's business model, revenue drivers, competitive position, and its relevance to US investors seeking exposure to the specialized life science real estate sector.
Lima airport warehouse space expands for auto parts as rents jump
Logistic Properties of the Americas (LPA) announced an expanded lease agreement with Scharff Logística Integrada S.A. at Parque Logístico Callao in Lima, Peru. Scharff will lease an additional 38,438 square feet for auto parts distribution, with the expansion commencing June 1, 2026, at double-digit increased rental rates. This move highlights strong demand for high-quality, airport-adjacent logistics facilities in Lima and LPA's strategy to capture embedded rental growth.
Zacks Research Issues Positive Forecast for ARE Earnings
Zacks Research has slightly increased its Q2 2026 EPS estimate for Alexandria Real Estate Equities (ARE) to $1.63, maintaining a "Hold" rating on the stock. The firm's full-year 2026 earnings outlook remains around $6.40 per share, with a projection of $5.92 EPS for FY2027. This positive forecast comes despite ARE reporting Q1 earnings in line with expectations but with revenue declining 11.5% year-over-year.
Alexandria Real Estate Equities stock (US0152711022): solid Q1 2026 results and steady life?science demand
Alexandria Real Estate Equities (ARE) reported strong Q1 2026 earnings, reiterating its leadership in the specialized US life-science REIT sector. The company showed year-over-year growth in rental revenue and funds from operations, driven by new development projects and increased rental rates. ARE continues to focus on its niche of life-science and innovation-oriented properties, with performance influenced by interest rates and biotechnology market conditions.
Goldman Sachs Maintains Alexandria Real Estate Equities Inc(ARE.US) With Hold Rating, Cuts Target Price to $52
Goldman Sachs has reiterated its Hold rating on Alexandria Real Estate Equities Inc (ARE.US) but has reduced its target price for the stock from $55 to $52. This adjustment suggests a slightly more cautious outlook from the investment bank regarding the company's future stock performance.
Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day
Alexandria Real Estate Equities Inc. (ARE) saw its stock rise by 4.36% to $47.84 on Wednesday, outperforming competitors during a strong trading session for the broader stock market. The S&P 500 Index and Dow Jones Industrial Average also rose significantly. Despite this, the stock remains 45.78% below its 52-week high of $88.24 reached in September.
Zacks Research Has Bullish Forecast for ARE FY2026 Earnings
Zacks Research has slightly increased its FY2026 EPS forecast for Alexandria Real Estate Equities (NYSE:ARE) to $6.40, aligning with the current consensus. Despite this, the firm maintains a "Hold" rating, mirroring cautious sentiment from other analysts who have cut price targets. Insider buying by executives and a recent quarterly dividend of $0.72 per share were also noted, alongside the stock trading below its 200-day moving average.
Truist Financial Corp Cuts Stake in Alexandria Real Estate Equities, Inc. $ARE
Truist Financial Corp significantly reduced its stake in Alexandria Real Estate Equities (NYSE:ARE) by 8
Essential Properties Realty (EPRT) Receives a Buy from Barclays
Barclays has reiterated a Buy rating for Essential Properties Realty (EPRT) with a $40.00 price target, following a strong earnings report for the quarter ending March 31, where the company reported increased revenue and net profit. Despite negative corporate insider sentiment with increased selling activity, other analysts like Mizuho Securities also issued a Buy, while Scotiabank maintained a Hold.
Analysts Offer Insights on Real Estate Companies: W. P. Carey Inc. (WPC) and Big Yellow Group (OtherBYLOF)
Barclays has maintained a Sell rating on W. P. Carey Inc. (WPC) with a price target of $78.00, while the consensus for WPC is a Hold with a $76.10 target. For Big Yellow Group (BYLOF), Barclays maintained a Buy rating with a target of £12.00, and the overall analyst consensus is a Hold with a $14.08 target. These ratings highlight divergent analyst opinions within the Real Estate sector for these two companies.
Welltower stock (US95040Q1040): REIT extends health-care push as shares trade near record levels
Welltower Inc. (US95040Q1040) is gaining renewed investor attention as its stock trades near record levels at $216.22 on May 20, 2026. The REIT specializes in senior housing and health-care properties, offering exposure to the aging population demographic in the US and Canada. Its business model, focused on lease income and property operations, makes its performance sensitive to occupancy rates, rent growth, and interest-rate expectations.
Alexandria Real Estate Equities stock (US0152711022): Latest catalyst and business snapshot
Alexandria Real Estate Equities (ARE) is a US-listed life-science real estate company that focuses on developing and operating properties for biotech, pharma, and research companies. The company's performance is tied to biotechnology spending, lab demand, and capital market conditions, making it a proxy for the health of life-science capital formation. For investors, ARE offers exposure to specialized real estate assets in major US innovation hubs, distinct from conventional office REITs.
Alexandria Real Estate Equities stock (US0152711022): Dividend hike and guidance update put focus on life-science REIT
Alexandria Real Estate Equities (ARE) has increased its quarterly dividend and reaffirmed its 2026 outlook after strong first-quarter results, drawing attention from income-focused investors. The REIT specializes in life-science and technology campuses, providing stable rental income through long-term leases with credit-worthy tenants. This focus on a specialized niche, combined with its REIT structure, makes it relevant for US investors seeking exposure to the innovation ecosystem and dividends.
Alexandria Real Estate Equities Inc. stock outperforms competitors despite losses on the day
Shares of Alexandria Real Estate Equities Inc. (ARE) decreased by 1.80% to $45.84, even as the broader stock market saw a rough trading session with the S&P 500 Index and Dow Jones Industrial Average also falling. Despite the daily loss, Alexandria Real Estate Equities Inc. closed 48.05% below its 52-week high, indicating a significant drop from its peak in September. This article highlights the company's performance relative to the overall market on a specific trading day.
Goldman Sachs Maintains Alexandria Real Estate Equities Inc(ARE.US) With Hold Rating, Cuts Target Price to $52
Goldman Sachs has reiterated its Hold rating on Alexandria Real Estate Equities Inc (ARE.US) while simultaneously reducing its target price for the stock to $52. This adjustment reflects the analyst's updated outlook on the company's valuation or future performance.
R9L0 Bond Price and Chart — FWB:R9L0
This article provides key financial data and an overview of the ACRES Commercial Realty Corp. 7.875% Cumulative Convertible Redeemable Perpetual Preferred Registered Shares Series -D- bond (R9L0) listed on the Frankfurt Stock Exchange. It details the bond's outstanding amount, face value, issuer information, sector, industry, issue date, and ISIN. The company itself is a real estate investment trust focused on commercial mortgage loans and related debt investments, founded in 2005.
Alexandria Real Estate Equities Inc (ARE) Shares Surge 3.8% -- What GF Score of 59 Tells Investors
Alexandria Real Estate Equities Inc (ARE) saw its shares rise 3.8% to $46.68, placing it 52.1% undervalued compared to its GF Value™ of $97.40, according to GuruFocus. Despite this apparent undervaluation, a GF Score™ of 59/100 and a "Possible Value Trap" label suggest caution due to concerns about financial strength, growth prospects, and higher-than-historical P/E ratios. Insider net purchases of $0.9M, however, indicate some positive sentiment among company executives.
Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day
Shares of Alexandria Real Estate Equities Inc. (ARE) rose 3.80% to $46.68 on Monday, outperforming the broader market during a mixed trading session. This gain snapped a two-day losing streak for the stock. The Dow Jones Industrial Average saw a slight increase, while the S&P 500 Index experienced a minor decline.
Alexandria Real Estate Equities stock (US0152711022): Life science REIT updates investors after rece
Alexandria Real Estate Equities, a US-focused REIT specializing in life science and technology campuses, has updated investors on its recent quarterly results and portfolio metrics. The company's core business model focuses on owning, developing, and operating properties in key innovation markets, primarily generating revenue from rental income. The article details its business model, revenue drivers, recent financial performance, portfolio composition, and capital allocation strategy, emphasizing its importance for US investors seeking exposure to the life science and tech real estate sectors.
Alexandria Real Estate Equities stock (US0152711022): analysts weigh upside as life science REIT stays in focus
Analysts are highlighting a moderate upside for Alexandria Real Estate Equities, a life science-focused REIT, amidst reassessment of the US office and lab real estate sector. The company's unique business model, centered on specialized campuses for life science and technology tenants, contributes to its stability, despite headwinds from higher interest rates. The stock represents a targeted investment in the US innovation economy for investors.
A Look At Alexandria Real Estate Equities (ARE) Valuation After Earnings Beat And Sector Downgrades
Alexandria Real Estate Equities (ARE) has seen its share price fall despite an earnings beat and steady governance, due to sector downgrades in life science real estate. The company is considered undervalued with a fair value of $88 compared to its last close of $44.97, based on a NAV per share of approximately $98, even with risks like declining rents, property impairments, and venture investment uncertainties. Investors are encouraged to look beyond the immediate concerns and explore potential hidden value, while considering fundamental data and specific risks outlined in the valuation narrative.
A Look At Alexandria Real Estate Equities (ARE) Valuation After Earnings Beat And Sector Downgrades
Alexandria Real Estate Equities (ARE) recently held its shareholder meeting, confirming board elections and executive pay approvals, with earnings surpassing forecasts despite revenue and sector downgrades. The stock has seen a 7.5% decline in the past month and a 34.2% fall in the 1-year total shareholder return, reflecting cooling sentiment. Despite this, the company is considered approximately 48.9% undervalued with a fair value of $88 compared to its last close of $44.97, based on NAV per share and accounting for sector risks like declining rents and property impairments.
A Look At Alexandria Real Estate Equities (ARE) Valuation After Earnings Beat And Sector Downgrades
Alexandria Real Estate Equities (ARE) is under scrutiny after its shareholder meeting and earnings beat, despite a decline in share price and sector downgrades. The company's valuation suggests it is significantly undervalued, with a fair value of $88 compared to its last close of $44.97, largely based on its NAV per share and FFO power. However, risks like declining occupancy and potential asset sale failures could impact this thesis.
Senior Housing Prop stock (US81721M1099): REIT pivots to Diversified Healthcare name amid portfolio challenges
Senior Housing Prop, now known as Diversified Healthcare Trust, is navigating a difficult healthcare real estate market by reshaping its portfolio strategy. The REIT is focusing on senior housing, medical office, and life science properties in the US, balancing rising interest rates and operating costs with improving occupancy and demand for outpatient medical space. Management's efforts to stabilize cash flows and adapt its balance sheet are key to its future performance.
ProShares UltraShort Real Estate stock (US8551791024): inverse REIT ETF in focus after recent sector swings
The ProShares UltraShort Real Estate ETF (SRS), which aims for two times the inverse daily performance of the Dow Jones U.S. Real Estate Index, is gaining attention amidst continued volatility in REIT and property stocks in 2026. This leveraged ETF utilizes derivatives for its inverse exposure, making it a tool for bearish bets or hedging existing REIT portfolios. While offering short-term trading opportunities, ProShares emphasizes its complexity, derivative risks, and suitability primarily for short-term speculation rather than long-term investment.
What Alexandria Real Estate Equities (ARE)'s Mixed Q1 Beat Amid Sector Headwinds Means For Shareholders
Alexandria Real Estate Equities reported mixed Q1 2026 results, with earnings surpassing expectations but revenue falling short due to challenging conditions in the life science real estate sector. Broker downgrades and sector headwinds like oversupply and regulatory uncertainty have impacted the company's investment narrative, leading to a downward revision in the 12-month analyst price target to US$51 with a consensus Hold rating. Despite a projected fair value of $55.50 (a 23% upside), the article emphasizes the need for investors to consider various perspectives, including bearish views, before making investment decisions.
Alexandria Real Estate Equities Inc. stock underperforms Friday when compared to competitors
Alexandria Real Estate Equities Inc. (ARE) stock fell by 2.60% on Friday, closing at $44.97, underperforming its competitors and the broader market. This drop occurred during a challenging trading session where the S&P 500 Index declined by 1.24% and the Dow Jones Industrial Average fell by 1.07%. This marked the second consecutive day of losses for the stock.
Alexandria Real Estate Equities stock (US0152711022): annual meeting keeps focus on REIT
Alexandria Real Estate Equities' 2026 annual meeting saw stockholders elect directors and approve key proposals, maintaining focus on its specialized life science campus portfolio. The REIT's core business model continues to revolve around rental income from laboratory and office spaces in major US innovation hubs, connecting its performance to the health of the biotech and pharmaceutical sectors. The meeting confirmed board continuity and no strategy shift, anchoring the stock's future performance to operating trends, leasing, and development progress.
Alexandria Real Estate Equities (ARE) Stock Price, News & Analysis $ARE
This article provides an in-depth analysis of Alexandria Real Estate Equities (ARE) stock, covering its price, news, and various financial metrics. It highlights the company's focus on life science and technology campuses, its "Hold" consensus rating from analysts, and details on insider transactions and dividend performance. The report also includes key statistics, ownership information, and recent news headlines related to ARE.
Alexandria Real Estate Equities stock (US0152711022): earnings outlook and life science focus draw a
Alexandria Real Estate Equities, a US-listed REIT focused on life science campuses, recently released quarterly figures and updated its 2024 guidance. The article details the company's business model, which centers on owning and developing specialized laboratory and office spaces in major US innovation hubs like Boston and San Francisco. It highlights that rental income is the primary driver, with long-term prospects depending on maintaining high-quality tenants and navigating market cycles.
3 TSX Stocks Estimated To Be Up To 49.8% Below Intrinsic Value
As global markets improve, Canadian investors are looking for undervalued stocks. This article highlights three TSX-listed companies—Avino Silver & Gold Mines (TSX:ASM), Magellan Aerospace (TSX:MAL), and Strathcona Resources (TSX:SCR)—that are estimated to be trading significantly below their intrinsic value based on discounted cash flow analysis. While each presents promising growth forecasts, concerns such as insider selling or past dilution are noted.
RBC Capital Keeps Their Hold Rating on Healthcare Realty Trust (HR)
RBC Capital has maintained a Hold rating on Healthcare Realty Trust (HR) with a price target of $21.00, following the company's shares closing at $20.37. Analyst Michael Carroll, known for his work in the Real Estate sector, issued the report after the company posted quarterly revenue of $278.99 million and a net profit of $21 thousand. Insider sentiment for HR is positive, with an increase in insider buying over the past quarter.
Baird maintains Alexandria Real Estate Equities (ARE) outperform recommendation
Baird has reiterated its "outperform" recommendation for Alexandria Real Estate Equities (ARE). This indicates the firm's continued positive outlook on the real estate investment trust specializing in life science campuses. The specific reasons for maintaining the rating were not detailed in this snippet.
Alexandria Real Estate Equities shareholders elect directors and approve key proposals
Alexandria Real Estate Equities (NYSE:ARE) shareholders elected eight directors and approved key proposals at their 2026 Annual Meeting. The company, a healthcare REIT with a 30-year dividend history, also confirmed the compensation of executive officers and ratified Ernst & Young LLP as its independent accountants. These actions follow the company's recent Q1 2026 earnings, which significantly beat EPS expectations but missed revenue forecasts, alongside analyst downgrades due to concerns over recovery timelines and market challenges.
Alexandria Real Estate Equities shareholders elect directors and approve key proposals
Alexandria Real Estate Equities (NYSE:ARE) shareholders elected eight directors and approved key proposals including executive compensation and the ratification of Ernst & Young LLP as independent public accountants during their 2026 Annual Meeting. The company maintains a 30-year dividend payment history and a 6.09% yield. These decisions follow recent financial reports where the company exceeded EPS forecasts but missed revenue expectations, and received downgrades from analysts citing a slower recovery.
Alexandria Real Estate Equities shareholders elect directors and approve key proposals
Alexandria Real Estate Equities, Inc. shareholders recently elected eight directors to its board and approved key proposals, including executive compensation and the ratification of Ernst & Young LLP as their independent registered public accountants. This comes as the healthcare REIT with a $8.06 billion market cap maintains a 6.09% dividend yield. The company also recently reported first-quarter earnings that significantly exceeded estimates, though revenue fell short, and has seen recent downgrades from analysts due to concerns about recovery timelines and property oversupply.
Alexandria Real Estate Equities Inc. stock underperforms Thursday when compared to competitors
Shares of Alexandria Real Estate Equities Inc. (ARE) fell 2.33% on Thursday, closing at $46.17. This underperformance occurred on a day when the broader market saw gains, with the S&P 500 Index (SPX) rising 0.77% and the Dow Jones Industrial Average (DJIA) increasing by 0.75%. The stock's decline ended a two-day winning streak.
Alexandria Real Estate Equities stock (US0108601063): Insider buys signal confidence amid Q1 results
Alexandria Real Estate Equities (NYSE:ARE) has seen significant insider buying totaling $1.81 million over the last 90 days, including a substantial purchase by Chairman Joel S. Marcus. This comes despite a dip in Q1 2026 revenue to $671.02 million, with the company maintaining its FY 2026 EPS guidance of $6.30-$6.50. The REIT, specializing in life science real estate, continues to attract US investors interested in the growing biotech sector.
Wall Street Analysts Are Bullish on Top Real Estate Picks
Wall Street analysts are showing bullish sentiment towards two real estate companies: Bluerock Homes Trust, Inc. Class A (BHM) and Global Self Storage (SELF). Analysts Barry Oxford and Gaurav Mehta have reiterated Buy ratings for these companies, setting price targets that suggest potential upside. The positive outlook is based on their analysis of the companies' current share prices and market performance.
Alexandria Real Estate Equities stock (US0108601063): Insider buys signal confidence amid Q1 results
Alexandria Real Estate Equities (ARE) has seen significant insider buying activity, totaling $1.81 million over the past 90 days, including a substantial purchase by Chairman Joel S. Marcus. This comes as the company reported Q1 2026 revenue of $671.02 million and issued FY 2026 EPS guidance of $6.30-$6.50, demonstrating resilience in the life sciences real estate market despite revenue challenges and a volatile stock performance. The insider confidence and the company's strong positioning in US innovation clusters suggest potential for long-term growth for investors.
Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day
Shares of Alexandria Real Estate Equities Inc. (ARE) rose 1.66% to $47.27 on Wednesday, outperforming the mixed market performance where the S&P 500 increased and the Dow Jones Industrial Average fell. This marks the second consecutive day of gains for the stock.
Alexandria Real Estate Equities stock (US0152711022): Analyst targets surge 32% amid life sciences demand
Alexandria Real Estate Equities (ARE), a prominent REIT specializing in life science and technology campuses, is seeing a significant rise in analyst price targets, with an average 12-month target of $99.08, indicating a potential 32% upside. Despite facing shareholder activism regarding governance, the company benefits from sustained demand in the life sciences sector. This upward trend in targets reflects strong market confidence in ARE's strategic positioning within specialized real estate.
Alexandria Real Estate Equities stock (US0152711021): Analyst targets climb amid governance pressure
Alexandria Real Estate Equities faces shareholder scrutiny over governance issues despite analysts raising average price targets to $99.08. The company specializes in life science real estate within US innovation hubs, relying on long-term leases and development projects for revenue. Insider buying by Chairman Joel S. Marcus also indicates internal confidence in the company's prospects.
Is Alexandria Real Estate Equities (ARE) Pricing Reflect A Potential Recovery After Multi‑Year Slide?
This article analyzes Alexandria Real Estate Equities (ARE) to determine if its current pricing of US$46.50 reflects a potential recovery after a multi-year decline. Using Discounted Cash Flow and Price to Sales analyses, Simply Wall St assesses the stock as undervalued, suggesting a significant gap between its current market price and its estimated intrinsic value. The article encourages investors to consider these valuation approaches and their own narratives to decide on the stock's attractiveness.
Pushed out by AI in S.F., a cancer-focused biotech regroups with new space in South City
Olema Pharmaceuticals, a cancer-focused biotech company, has secured new office space in South San Francisco after being pushed out of its former San Francisco location by OpenAI. The company is actively hiring for 20 open positions as it prepares for a potential commercial launch, highlighting the impact of AI growth on real estate in the Bay Area.
Alexandria Real Estate Equities, Inc. Stock 12‑Month Price Target Cut to $51.25, Implies 10% Upside
The average 12-month price target for Alexandria Real Estate Equities, Inc. (ARE) stock has been lowered from $51.92 to $51.25 by 12 analysts, implying a 10% potential upside from its May 12th closing price. The consensus rating from 15 analysts remains "Hold," with a breakdown of 2 Buys, 11 Holds, and 2 Sells. This information allows investors to explore further price target data and analyst recommendations.
Alexandria Real Estate Equities stock (US0108601063): Insider Buying and Recent Analyst Updates
Alexandria Real Estate Equities (NYSE:ARE) has seen significant insider buying activity, with Chairman Joel S. Marcus and other insiders purchasing $1.81 million worth of shares over the past 90 days. The company, which specializes in life science real estate, reported a Q1 2026 revenue of $671.02 million and issued FY 2026 EPS guidance of $6.30-$6.50, despite facing revenue declines and negative margins. Analysts currently maintain a Hold consensus rating with a target price of $51.92.
Invitation Homes stock (US46187W1071): Leading S&P 500 single-family rental firm
Invitation Homes is the largest single-family home leasing company, managing over 80,000 homes primarily in high-demand Sun Belt markets. The company operates as a residential REIT, acquiring, renovating, and leasing properties, with rental income as its main driver. Invitation Homes leads the institutional rental segment and offers investors exposure to the residential real estate market through its dividend-paying REIT structure.
Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day
Alexandria Real Estate Equities Inc. (ARE) saw its stock rise by 1.09% to $46.50 on Tuesday, despite a mixed trading session for the broader market. This performance allowed ARE to outperform some competitors, even as the Dow Jones Industrial Average rose slightly and the S&P 500 Index experienced a minor decline. The company's stock, however, remains significantly below its 52-week high.
Naples Global Advisors LLC Cuts Holdings in Alexandria Real Estate Equities, Inc. $ARE
Naples Global Advisors LLC significantly reduced its stake in Alexandria Real Estate Equities, Inc. (ARE) by 61.5% in the fourth quarter, holding 20,112 shares valued at $997,000. Despite this, company insiders, including EVP Gregory Calvin Thomas and Chairman Joel S. Marcus, have recently purchased a total of 36,000 shares worth $1.81 million. The company reported flat EPS of $1.73 and an 11.5% year-over-year revenue decline, with analysts maintaining a "Hold" consensus and an average target price of $51.92.
